$ジオバックス・ラブズ(GOVX.US)$GeoVax Labs Anticipates Reporting Additional Results From the Gedeptin Phase 1/2 Clinical Trial in 1H 2024>GOVX Dow Jones· 2 mins ago
Dr. Pipas' appointment is a crucial move in bolstering GeoVax's resources for the progression of Gedeptin(R) and the firm's wider immune-oncology portfolio. His expertise is anticipated to aid the clinical developments of GeoVax's oncology programs.
$ジオバックス・ラブズ(GOVX.US)$GeoVax Announces Issuance of Malaria Vaccine Patent, Patent Covers Multiple Component Vaccine For Both Prevention And Treatment Benzinga· 3 mins ago
ジオバックス・ラブズに関するコメント
Keep on watch
Dow Jones· 2 mins ago
Replaced $キンタラ・セラピューティクス(KTRA.US)$ to $ジオバックス・ラブズ(GOVX.US)$
+ $HUB Cyber Security(HUBC.US)$ & $U Power(UCAR.US)$
$ジオバックス・ラブズ(GOVX.US)$
🚨⚡️🚨⚡️🚨⚡️
📊⚡️📊
Update
Benzinga· 3 mins ago
Small position
Covid outbreak possible play watch closely
$ジオバックス・ラブズ(GOVX.US)$
$ノババックス(NVAX.US)$
まだコメントはありません